CompaniesByCap
ICCC
ImmuCell Corporation (ICCC)
NASDAQ · Healthcare

ImmuCell Corporation Cash Flow 2017–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Cash Flow2.5M357,903-4.7M-1.5M954,1701.3M233,511-373,4041.2M-222,3142.9M302,3641.1M344,390-37,315-808,613-109,665
Depreciation & Amort.2.8M2.7M
Investing Activities
Capital Expenditure1.3M465,7251.9M4.0M2.6M4.1M1.4M2.0M17.8M3.6M2.7M1.5M597,697275,395243,735116,547459,548
Free Cash Flow1.2M-107,822-6.6M-5.5M-1.7M-2.8M-1.2M-2.4M-16.6M-3.8M181,047-1.2M500,96368,995-281,050-925,160-569,213
Financing Activities
Dividends Paid
Stock Buybacks

ImmuCell Corporation Cash Flow — FAQ

ImmuCell Corporation (ICCC) cash flow over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ICCC's cash flow history?

The chart and table above show ImmuCell Corporation's cash flow by year and by quarter, including the growth rate.